富国中证医药50ETF联接A(012801)财务指标
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 本期已实现收益 |
-19,989,191.80 |
-8,078,578.95 |
8,250,721.74 |
-550,958.70 |
| 本期利润 |
-10,437,969.25 |
-16,098,249.45 |
-12,913,356.51 |
-8,919,538.52 |
| 加权平均基金份额本期利润 |
-0.11 |
-0.16 |
-0.11 |
-0.08 |
| 本期加权平均净值利润率(%) |
-14.54 |
-21.28 |
-12.85 |
-8.94 |
| 本期基金份额净值增长率(%) |
-11.16 |
-18.70 |
-9.66 |
-6.08 |
| 期末可供分配利润 |
-26,329,014.28 |
-31,695,587.73 |
-21,722,248.40 |
-17,980,105.79 |
| 期末可供分配基金份额利润 |
-0.27 |
-0.33 |
-0.18 |
-0.14 |
| 期末基金资产净值 |
71,534,824.17 |
64,045,600.36 |
100,868,106.75 |
106,353,659.42 |
| 期末基金份额净值 |
0.73 |
0.67 |
0.82 |
0.86 |
| 基金份额累计净值增长率(%) |
-26.90 |
-33.11 |
-17.72 |
-14.46 |
微信公众号
证券之星APP
基本资料
